Clinical Trial Update: The 90% Effective Sedation Dose Of Midazolam [NA]

View source ↗

Summary

This clinical trial update describes research on the 90% effective sedation dose of midazolam, sponsored by King Fahad Specialist Hospital Dammam. The listed co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease with Ulceration

Drugs mentioned

• Midazolam (Midazolam)

Snippet

Sponsor: King Fahad Specialist Hospital Dammam | Conditions: Gastro-Esophageal Reflux Disease With Ulceration | NA | Status: UNKNOWN